Overview

This trial is active, not recruiting.

Condition anemia
Treatment iron supplement
Sponsor Wolfson Medical Center
Collaborator Tel Aviv District of the Health Office
Trial identifier NCT00436202, Anemia

Summary

The purpose of the study is to determine whether improvement in the accessibility to iron supplement will decrease anemia rates in infants.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation non-randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking open label
Primary purpose prevention

Eligibility Criteria

Male or female participants at least 4 months old.

Inclusion Criteria: - Infant who visit Family Health Centers

Additional Information

Principal investigator Tamar Shohat, M.D., MPH
Description Iron deficiency anemia is the most common type of anemia in infants, children and women of reproductive age. The most frequent cause of iron deficiency in infants at 6 months of life is poor nutrition during a period of rapid growth and a diet lacking in iron rich foods. Children who suffered from anemia in infancy demonstrated slower cognitive development, were low achievers in school and had a high rate of behavioral disturbances. The Ministry of Health implements a primary prevention program for anemia. If by making iron supplements more accessible would increase parental compliance in acquisition of the iron supplement and subsequently reduce the rate of iron deficiency anemia, the result would be the immediate application of the finding. It is possible to implement a program whereby the supplement will be directly available at the family health centers for purchase by the parent.
Trial information was received from ClinicalTrials.gov and was last updated in September 2010.
Information provided to ClinicalTrials.gov by Wolfson Medical Center.